Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2019 | 2018 | 2016
Number of items: 3.

2019

Vieillard, Vincent, Combadiere, Behazine, Tubiana, Roland, Launay, Odile, Pialoux, Gilles, Cotte, Laurent, Girard, Pierre-Marie, Simon, Anne, Dudoit, Yasmine, Reynes, Jacques, Rockstroh, Juergen, Garcia, Felipe, Gatell, Jose, Devidas, Alain, Yazdanpanah, Yazdan, Weiss, Laurence, Faetkenheuer, Gerd, Autran, Brigitte, Joyeux, Delphine, Gharakhanian, Shahin, Debre, Patrice and Katlama, Christine (2019). HIV therapeutic vaccine enhances non-exhausted CD4(+) T cells in a randomised phase 2 trial. npj Vaccines, 4. LONDON: SPRINGERNATURE. ISSN 2059-0105

2018

Vieillard, Vincent, Combadiere, Behazine, Tubiana, Roland, Pialoux, Gilles, Cotte, Laurent, Girard, Pierre Marie, Simon, Anne, Reynes, Jacques, Rockstroh, Juergen, Gatell, Jose, Devidas, Alain, Yazdanpanah, Yazdan, Launay, Odile, Weiss, Laurence, Autran, Brigitte, Gharakhanian, Shahin, Faetkenheuer, Gerd, Costagliola, Dominique, Debre, Patrice and Katlama, Christine (2018). A Novel Approach to Inhibit CD4 Exhaustion: Results of a Placebo-controlled Phase II Study of a gp41 Peptide Vaccine in HIV-1 Patients Under ART. Aids Res. Hum. Retrovir., 34. S. 49 - 50. NEW ROCHELLE: MARY ANN LIEBERT, INC. ISSN 1931-8405

2016

Pett, Sarah Lilian, Amin, Janaki ORCID: 0000-0003-2161-9366, Horban, Andrejz, Andrade-Villanueva, Jaime, Losso, Marcelo, Porteiro, Norma, Sierra Madero, Juan, Belloso, Waldo, Tu, Elise, Silk, David, Kelleher, Anthony ORCID: 0000-0002-0009-3337, Harrigan, Richard, Clark, Andrew, Sugiura, Wataru, Wolff, Marcelo ORCID: 0000-0002-9956-8872, Gill, John, Gatell, Jose, Fisher, Martin, Clarke, Amanda, Ruxrungtham, Kiat, Prazuck, Thierry, Kaiser, Rolf, Woolley, Ian, Alberto Arnaiz, Juan, Cooper, David, Rockstroh, Jurgen K., Mallon, Patrick and Emery, Sean ORCID: 0000-0001-6072-8309 (2016). Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study. Clin. Infect. Dis., 63 (1). S. 122 - 133. CARY: OXFORD UNIV PRESS INC. ISSN 1537-6591

This list was generated on Sat May 4 03:41:09 2024 CEST.